167:
29:
575:
484:
Zhang SS, Liu M, Liu DN, Yang YL, Du GH, Wang YH (April 2022). "TLR4-IN-C34 Inhibits
Lipopolysaccharide-Stimulated Inflammatory Responses via Downregulating TLR4/MyD88/NF-κB/NLRP3 Signaling Pathway and Reducing ROS Generation in BV2 Cells".
237:
440:
Sivak KV, Stosman KI, Rassokha TA, Aleksandrov AG, Kuzmich NN, Orshanskaya YR, et al. (October 2020). "The Effect of TLR4 Blockade on Some
Indicators of Systemic Inflammatory Response to Proteus mirabilis LPS in Rats".
347:
Adegoke EO, Adeniran SO, Zeng Y, Wang X, Wang H, Wang C, et al. (June 2019). "Pharmacological inhibition of TLR4/NF-κB with TLR4-IN-C34 attenuated microcystin-leucine arginine toxicity in bovine
Sertoli cells".
393:"Lactobacillus salivarius BP121 prevents cisplatin‑induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p‑cresol sulfate via alleviating dysbiosis"
251:
279:
InChI=1S/C17H27NO9/c1-8(2)24-17-14(18-9(3)19)16(26-12(6)22)15(25-11(5)21)13(27-17)7-23-10(4)20/h8,13-17H,7H2,1-6H3,(H,18,19)/t13-,14-,15-,16-,17+/m1/s1
616:
271:
44:
635:
645:
650:
146:
609:
530:"TLR4-IN-C34 protects against acute kidney injury via modulating TLR4/MyD88/NF-κb axis, MAPK, and apoptosis"
135:
602:
302:
162:
640:
61:
510:
466:
373:
551:
502:
458:
422:
365:
115:
586:
541:
494:
450:
412:
404:
357:
310:
183:
166:
70:
546:
529:
417:
392:
28:
629:
514:
470:
95:
377:
582:
498:
454:
327:
213:
106:
20:
555:
506:
462:
426:
408:
369:
574:
306:
391:
Lee TH, Park D, Kim YJ, Lee I, Kim S, Oh CT, et al. (April 2020).
81:
361:
322:
126:
236:
227:
301:) is a drug which acts as a potent and selective antagonist of
151:
528:
Abdelsalam HM, Helal MG, Abu-Elsaad NM (November 2022).
590:
225:
212:
182:
177:
145:
125:
105:
80:
60:
35:
305:(TLR4). In animal studies it blocks TLR4-mediated
94:
69:
259:CC(C)O1((((O1)COC(=O)C)OC(=O)C)OC(=O)C)NC(=O)C
610:
443:Bulletin of Experimental Biology and Medicine
8:
19:
397:International Journal of Molecular Medicine
617:
603:
165:
114:
27:
545:
534:Iranian Journal of Basic Medical Sciences
416:
339:
276:
256:
161:
49:
18:
134:
7:
571:
569:
85:
589:. You can help Knowledge (XXG) by
14:
573:
200:
194:
284:Key:KMIQMFHPUJUDMC-HHARLNAUSA-N
203:
188:
1:
350:Journal of Applied Toxicology
667:
568:
499:10.1007/s10753-021-01588-8
455:10.1007/s10517-020-04981-9
178:Chemical and physical data
267:
247:
40:
26:
585:-related article is a
409:10.3892/ijmm.2020.4495
636:Receptor antagonists
303:Toll-like receptor 4
646:Oxygen heterocycles
23:
651:Pharmacology stubs
598:
597:
540:(11): 1334–1340.
292:
291:
238:Interactive image
147:CompTox Dashboard
16:Chemical compound
658:
619:
612:
605:
577:
570:
560:
559:
549:
525:
519:
518:
481:
475:
474:
437:
431:
430:
420:
403:(4): 1130–1140.
388:
382:
381:
362:10.1002/jat.3771
344:
311:antiinflammatory
309:release and has
240:
220:
205:
202:
196:
190:
170:
169:
155:
153:
138:
118:
98:
88:
87:
73:
31:
24:
22:
666:
665:
661:
660:
659:
657:
656:
655:
626:
625:
624:
623:
566:
564:
563:
527:
526:
522:
483:
482:
478:
439:
438:
434:
390:
389:
385:
346:
345:
341:
336:
319:
288:
285:
280:
275:
274:
263:
260:
255:
254:
243:
218:
208:
199:
193:
173:
163:DTXSID001336698
149:
141:
121:
101:
84:
76:
56:
53:
48:
47:
17:
12:
11:
5:
664:
662:
654:
653:
648:
643:
638:
628:
627:
622:
621:
614:
607:
599:
596:
595:
578:
562:
561:
520:
493:(2): 838–850.
476:
449:(6): 795–797.
432:
383:
356:(6): 832–843.
338:
337:
335:
332:
331:
330:
325:
318:
315:
290:
289:
287:
286:
283:
281:
278:
270:
269:
268:
265:
264:
262:
261:
258:
250:
249:
248:
245:
244:
242:
241:
233:
231:
223:
222:
216:
210:
209:
206:
197:
191:
186:
180:
179:
175:
174:
172:
171:
158:
156:
143:
142:
140:
139:
131:
129:
123:
122:
120:
119:
111:
109:
103:
102:
100:
99:
91:
89:
78:
77:
75:
74:
66:
64:
58:
57:
55:
54:
52:methyl acetate
51:
43:
42:
41:
38:
37:
33:
32:
15:
13:
10:
9:
6:
4:
3:
2:
663:
652:
649:
647:
644:
642:
639:
637:
634:
633:
631:
620:
615:
613:
608:
606:
601:
600:
594:
592:
588:
584:
579:
576:
572:
567:
557:
553:
548:
543:
539:
535:
531:
524:
521:
516:
512:
508:
504:
500:
496:
492:
488:
480:
477:
472:
468:
464:
460:
456:
452:
448:
444:
436:
433:
428:
424:
419:
414:
410:
406:
402:
398:
394:
387:
384:
379:
375:
371:
367:
363:
359:
355:
351:
343:
340:
333:
329:
326:
324:
321:
320:
316:
314:
312:
308:
304:
300:
296:
282:
277:
273:
266:
257:
253:
246:
239:
235:
234:
232:
229:
224:
217:
215:
211:
187:
185:
181:
176:
168:
164:
160:
159:
157:
148:
144:
137:
136:ChEMBL4303607
133:
132:
130:
128:
124:
117:
113:
112:
110:
108:
104:
97:
93:
92:
90:
83:
79:
72:
68:
67:
65:
63:
59:
50:
46:
39:
34:
30:
25:
591:expanding it
583:pharmacology
580:
565:
537:
533:
523:
490:
487:Inflammation
486:
479:
446:
442:
435:
400:
396:
386:
353:
349:
342:
298:
294:
293:
295:TLR4-IN-C34
221: g·mol
36:Identifiers
21:TLR4-IN-C34
641:Acetamides
630:Categories
334:References
328:Resatorvid
226:3D model (
214:Molar mass
107:ChemSpider
71:40592-88-9
62:CAS Number
45:IUPAC name
515:241108525
471:225058037
313:effects.
556:36474570
507:34727285
463:33098506
427:32124946
378:58948493
370:30671980
317:See also
307:cytokine
116:34500445
96:91691128
547:9699956
418:7053870
219:389.401
184:Formula
82:PubChem
554:
544:
513:
505:
469:
461:
425:
415:
376:
368:
323:M62812
252:SMILES
127:ChEMBL
581:This
511:S2CID
467:S2CID
374:S2CID
272:InChI
228:JSmol
587:stub
552:PMID
503:PMID
459:PMID
423:PMID
366:PMID
297:(or
542:PMC
495:doi
451:doi
447:169
413:PMC
405:doi
358:doi
299:C34
152:EPA
86:CID
632::
550:.
538:25
536:.
532:.
509:.
501:.
491:45
489:.
465:.
457:.
445:.
421:.
411:.
401:45
399:.
395:.
372:.
364:.
354:39
352:.
198:27
192:17
618:e
611:t
604:v
593:.
558:.
517:.
497::
473:.
453::
429:.
407::
380:.
360::
230:)
207:9
204:O
201:N
195:H
189:C
154:)
150:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
